Best Practice & Research Clinical Endocrinology & Metabolism
9ACTH-independent macronodular adrenal hyperplasia
Section snippets
Initial descriptions of AIMAH
AIMAH was first described in 19643, and by 1994 only 24 similar cases had been published.4 Since then, more cases have been reported, and the characteristics of the disease have been increasingly delineated.5, 6, 7, 8 Various terms have been used, including massive macronodular adrenocortical disease, autonomous macronodular adrenal hyperplasia, ACTH-independent massive bilateral adrenal disease, giant or huge macronodular adrenal hyperplasia, and macronodular adrenal dysplasia.5, 6, 7, 8
AIMAH
Epidemiology
AIMAH presents a bimodal age distribution, with a rare subset presenting in the first years of life particularly with the McCune–Albright syndrome.9 Most AIMAH patients present in the fifth and sixth decades, a later age of onset compared with unilateral adenomas or Cushing's disease.1, 4, 5 This is also later than PPNAD, which occurs at a mean age of 18 years.5, 10 In contrast to the predominantly female distribution in most cases of CS, AIMAH is equally distributed between genders.2, 4, 5, 8
Genetic causes of AIMAH
In the majority of cases AIMAH appears to be sporadic. Several reports of familial clustering have been published with an autosomal dominant pattern of transmission.12, 13, 14, 15, 16, 17, 18 The prevalence of familial forms of AIMAH is not yet known, as systematic familial screening has not been conducted. In recently studied families with AIMAH, aberrant hormone receptors have been identified in their adrenal tissues (see later section), but the genes implicated have not yet been identified.15
Clinical and Laboratory Features
Patients with AIMAH are identified either following an incidental radiological finding or the investigation of an adrenal over-secretion syndrome.2, 4, 5, 6, 7, 8, 24, 25 The most common clinical presentation is subclinical, followed by clinical CS. At the time of diagnosis of the latter, subtle signs and symptoms consistent with CS have typically been present for a number of years. In one series, the diagnosis was delayed by a mean of 7.8 years.7 Plasma ACTH becomes progressively suppressed
Imaging in AIMAH
On CT scan, bilateral adrenal nodules of soft tissue density, measuring up to 5 cm, distort the normal adrenal glands (Fig. 1).6, 35, 36 In some cases the adrenal glands appear diffusely enlarged but lack distinct nodules. On MRI, T1-weighted images are hypointense relative to the liver and isointense relative to muscle. T2-weighted images tend to be hyperintense relative to the liver.35, 36 In contrast, the nodules of patients with chronic ACTH stimulation appear isointense relative to the
Pathology
The combined adrenal weight is usually >60 g and can reach 200 g per gland. The mean combined weight in one series was 132 g.35 In patients with Cushing's disease it was 22.9 g in a series of 30 patients.38 On cut sections, the nodules are yellow due to their high lipid content.11 The nodules are composed of two cell types: either with clear cytoplasm (lipid-rich) that form cordon nest-like structures, or with compact cytoplasm (lipid-poor) that form nest- or island-like structures.11, 33 The
Pathophysiology of AIMAH
Evidence for a primary adrenal alteration was provided by initial in vitro cell cultures from AIMAH tissues with a high rate of growth and cortisol production.40 Constitutive ACTH receptor (MC2R) mutation is not a common cause of adrenal hyperplasia or tumor formation.41, 42 In one patient with AIMAH, a C-terminal MC2R mutation (F278C) led to impaired desensitization and internalization and elevated basal cAMP.43 In a patient with hypersensitivity to ACTH, two mutations (C21R or S247G) were
Molecular mechanisms of aberrant hormone receptors
The development and function of the adrenal cortex requires tissue-specific expression of the appropriate hormone receptors and regulatory mechanisms for these receptors, involving cis-acting regulatory elements (promoters) and trans-acting factors (transcription factors, co-activators and co-repressors). The GIPR has been the most extensively characterized ectopic receptor in AIMAH. GIPR gene sequence analysis did not reveal mutations of coding or putative promoter regions in adrenals of
Investigation protocol for aberrant receptors
Investigative protocols have been developed to screen patients with adrenal CS to identify the regulation of steroid production by one or several aberrant receptors.95, 96 The strategy consists of modulating the plasma levels of diverse hormone (endogenous or exogenous) ligands for the potential aberrant receptors, while monitoring plasma levels of cortisol, other steroid hormones and ACTH. All tests are performed following an overnight fast and with the patient in a supine position for at
Treatment of AIMAH
Bilateral adrenalectomy by overt or laparoscopic approach has been the most useful treatment in patients with AIMAH and hormonal hypersecretion.4, 5, 7, 8 However, in patients with moderately increased hormonal production, unilateral adrenalectomy has been proposed as a safe and effective alternative; it is expected that, as the cell mass increases in the contralateral adrenal, a second adrenalectomy may be necessary.89, 97, 98 In patients with subclinical AIMAH, the decision for therapy should
Summary
In recent years, several new findings have contributed to a better understanding of the heterogeneity of pathogenesis in AIMAH. Aberrantly expressed G-protein-coupled receptors in the adrenal cortex appear to play a central role in the hormonal hypersecretion and cell proliferation in this disease. However, other molecular mechanisms – such as Gsp or ACTH receptor mutations, and adrenal paracrine hormonal secretion – can also be implicated in this disease. Together, these studies have
Acknowledgements
This work was supported by grant MT-13-189 from Canadian Institutes of Health Research.
References (98)
- et al.
Cushing's syndrome
Lancet
(2006) - et al.
Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome
The Journal of Pediatrics
(1999) - et al.
Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia?
Life Sciences
(1995) - et al.
Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missence mutations in the MC2R gene
Molecular and Cellular Endocrinology
(2004) - et al.
McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy
The Journal of Pediatrics
(1968) - et al.
Cushing syndrome, sexual precocity, and polyostotic fibrous dysplasia (Albright syndrome) in infancy
The Journal of Pediatrics
(1975) - et al.
Cushing's syndrome variants secondary to aberrant hormone receptors
Trends in Endocrinology and Metabolism
(2004) - et al.
Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome
The Journal of Steroid Biochemistry and Molecular Biology
(2004) - et al.
Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome
Endocrine Reviews
(2001) - et al.
Cushing's Syndrome: Nodular cortical hyperplasia of adrenal glands with clinical and pathological features suggesting adrenocortical tumor
The Journal of Clinical Endocrinology and Metabolism
(1964)
ACTH-independent massive bilateral adrenal disease (AIMBAD): a subtype of Cushing's syndrome with major diagnostic and therapeutic implications
European Journal of Endocrinology
Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome
Hormone and Metabolic Research
Adrenocorticotropin-independent macronodular adrenal hyperplasia: an uncommon cause of primary adrenal hypercortisolism
Radiology
Corticotropin-independent macronodular adrenal hyperplasia: a clinicopathologic correlation
Archives of Surgery
Adrenocorticotropic hormone-independent adrenal hyperplasia
The Endocrinologist
Primary bilateral adrenocortical causes of Cushing's syndrome
Surgery
Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature
American Journal of Clinical Pathology
Familial adrenocorticotropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia
The Journal of Clinical Endocrinology and Metabolism
ACTH independent Cushing's syndrome occurring in siblings
Clinical Endocrinology
Familial ACTH-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia clinically affecting only female family members
Experimental and Clinical Endocrinology & Diabetes
Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines: detection of the aberrant hormone receptors on adrenal gland
Endocrine
Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia
Clinical Endocrinology
Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors
European Journal of Endocrinology
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1
The Journal of Clinical Endocrinology and Metabolism
Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1
Archives of Surgery
Adrenocorticotropin-independent macronodular adrenocortical hyperplasia associated with multiple colon adenomas/carcinomas which showed a point mutation in the APC gene
Internal Medicine
Adrenal masses in patients with familial adenomatous polyposis
Diseases of the Colon and Rectum
Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation
The Journal of Clinical Endocrinology and Metabolism
Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids
Internal Medicine
Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome
The Journal of Clinical Endocrinology and Metabolism
A natural history of adrenocorticotropin-independent bilateral adrenal macronodular hyperplasia (AIMAH) from preclinical to clinically overt Cushing's syndrome
Endocrine Journal
A case of Cushing's syndrome due to ACTH-independent bilateral macronodular hyperplasia associated with excessive secretion of mineralocorticoids
Endocrine Journal
Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome
The Journal of Clinical Endocrinology and Metabolism
Virilization in bilateral macronodular adrenal hyperplasia controlled by luteinizing hormone
The Journal of Clinical Endocrinology and Metabolism
Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing's syndrome
Clinical Endocrinology
Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?
The Journal of Clinical Endocrinology and Metabolism
ACTH-independent macronodular adrenocortical hyperplasia: immunohistochemical and in situ hybridization studies of steroidogenic enzymes
Modern Pathology
Bilateral adrenocortical adenomas causing Cushing's syndrome. Report of two cases with enzyme histochemical and ultrastructural studies and a review of the literature
Archives of Pathology & Laboratory Medicine
CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism
Journal of Computer Assisted Tomography
CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome
Radiographics
Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome
The Journal of Clinical Endocrinology and Metabolism
Macronodular adrenocortical hyperplasia in long-standing Cushing's disease
The Journal of Clinical Endocrinology and Metabolism
‘GIANT’ macronodular adrenal hyperplasia causing Cushing's syndrome: case report and review of the literature on a clinical distinction of adrenocortical nodular pathology associated with hypercortisolism
Endocrinologia Japonica
Cushing's syndrome due to bilateral adrenal macronodular hyperplasia with undetectable ACTH: cell culture of adenoma cells on extracellular matrix
Hormone Research
No evidence for oncogenic mutations in the adrenocorticotropin receptor gene in human adrenocortical neoplasms
The Journal of Clinical Endocrinology and Metabolism
Impaired desensitization of a mutant adrenocorticotropin receptor associated with apparent constitutive activity
Molecular Endocrinology
The McCune-Albright syndrome
Acta Endocrinologica. Supplementum
Cited by (147)
Obesity and its comorbidities, current treatment options and future perspectives: Challenging bariatric surgery?
2023, Pharmacology and TherapeuticsPrimary bilateral macronodular adrenal hyperplasia: A series of 32 cases and literature review
2023, Endocrinologia, Diabetes y NutricionKDM1A inactivation causes hereditary food-dependent Cushing syndrome
2022, Genetics in MedicineCitation Excerpt :This suggests that KDM1A explains the vast majority of FDCS PBMAH and clearly establishes that this is a genetic disease. In the literature, most patients with FDCS are female.3,13-16,22,23 In keeping with this observation, all the patients with KDM1A pathogenic variants in this study are female, whereas such increased prevalence among females is not observed in the patients with an ARMC5 pathogenic variant.
Primary pigmented nodular adreno-cortical disease
2021, Diagnostic HistopathologyCitation Excerpt :Bilateral adrenal hyperplasia accounts for less than 5% of ACTH-independent cases and are sub-classified as macro- or micro-nodular based on a size threshold of 1 cm.2 Primary pigmented nodular adreno-cortical disease (PPNAD) is an uncommon, but important, entity within the category of bilateral adrenal hyperplasia.2 Interpretation of pre-operative findings in patients with PPNAD can be challenging.